EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Clinical efficacy of intravenous amiodarone in the short term treatment of recurrent sustained ventricular tachycardia and ventricular fibrillation



Clinical efficacy of intravenous amiodarone in the short term treatment of recurrent sustained ventricular tachycardia and ventricular fibrillation



British Heart Journal 62(5): 367-371



The clinical efficacy of intravenous amiodarone in terminating sustained ventricular tachycardia and in preventing recurrences of ventricular tachycardia and ventricular fibrillation was evaluated in 26 patients. All of them presented with organic heart disease accompanied by depressed left ventricular function. Intravenous amiodarone terminated spontaneous ventricular tachycardia in eight of 19 patients. Fifteen of the 26 patients had had at least one episode of ventricular tachycardia or ventricular fibrillation each day in the period immediately before the intravenous administration of amiodarone. Amiodarone controlled ventricular tachycardia or ventricular fibrillation in nine of these 15 patients; in three further cases it was successful when supplemented by additional administration of a previously ineffective antiarrhythmic drug and ventricular pacing. Two patients died despite these measures. In one, the amiodarone infusion had to be stopped because of an arrhythmogenic effect. Sustained deterioration of haemodynamic function or of pre-existing intraventricular conduction disturbances was never seen. Intravenous amiodarone was effective in terminating sustained ventricular tachycardia and in preventing frequent episodes of ventricular arrhythmia that were refractory to other antiarrhythmic drugs.

(PDF emailed within 0-6 h: $19.90)

Accession: 007120254

Download citation: RISBibTeXText

PMID: 2590589

DOI: 10.1136/hrt.62.5.367



Related references

Clinical efficacy of amiodarone in treatment of recurrent ventricular tachycardia and ventricular fibrillation. American Heart Journal 106(4 Pt 2): 887-894, 1983

Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation. Journal of the American College of Cardiology 13(2): 442-449, 1989

Intravenous amiodarone for short-term treatment of refractory ventricular tachycardia or fibrillation. American Heart Journal 122(6): 1629-1632, 1991

Efficacy of intravenous amiodarone as short-term treatment for refractory ventricular tachycardia. American Heart Journal 115(1 Pt 1): 96-101, 1988

Stratification of sudden death risk in patients receiving long-term amiodarone treatment for sustained ventricular tachycardia or ventricular fibrillation. American Journal of Cardiology 71(10): 823-826, 1993

Clinical experience with amiodarone for treatment of recurrent ventricular tachycardia and ventricular fibrillation. British Journal of Clinical Practice. Supplement 44: 16-27, 1986

Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Group. Circulation 92(11): 3255-3263, 1995

Safety and efficacy of intravenous amiodarone in patients with ventricular tachycardia and ventricular fibrillation. Clinical Research 36(1): 3A, 1988

Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation. New England Journal of Medicine 305(10): 539-545, 1981

Long-term results of amiodarone therapy in patients with sustained ventricular tachycardia or ventricular fibrillation for prevention of cardiac sudden death. Japanese Circulation Journal 58 Suppl 4: 1309-1312, 1994

Intravenous amiodarone for recurrent polymorphic ventricular tachycardia and ventricular fibrillation related to acute myocardial infarction or coronary artery bypass surgery. Circulation 90(4 PART 2): I545, 1994

Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation. American Journal of Cardiology 52(8): 975-979, 1983

Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study. American Journal of Cardiology 61(13): 1024-1030, 1988

Cardiac arrest and sudden death in patients treated with amiodarone for sustained ventricular tachycardia of ventricular fibrillation risk stratification based on clinical variables. American Journal of Cardiology 55(4): 372-374, 1985

Long term clinical efficacy of electrophysiologically guided amiodarone therapy for refractory sustained ventricular tachycardia. Clinical Researchpart 1: 204a, 1985